Overview

Study of the Effects of Artificial Tears on the Response to the Latanoprost Punctal Plug Delivery System in Subjects With Ocular Hypertension or Open-Angle Glaucoma

Status:
Completed

Trial end date:
2009-12-01

Target enrollment:
0

Participant gender:
All

Summary

The purpose of this study is to determine the effect of artificial tears preserved with Benzalkonium Chloride (AT-BAK) on the IOP response to the L-PPDS and to evaluate the safety of the L-PPDS in subjects with OH or OAG following treatment.

Phase:

Phase 2

Accepts Healthy Volunteers?

Details

Lead Sponsor:

Mati Therapeutics Inc.

Treatments:

Benzalkonium Compounds
Latanoprost
Lubricant Eye Drops

Criteria

Inclusion Criteria:

- Over 18 years with ocular hypertension or open-angle glaucoma

- Subjects who have a best-corrected visual acuity of 20/100 or better

Exclusion Criteria:

- Subjects who wear contact lenses

- Uncontrolled medical conditions

- Subjects with a known sensitivity to latanoprost, BAK, or any other products required
for the study

- Subjects requiring chronic topical artificial tears, lubricants, and/or requiring any
other chronic topical medications.